mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-05 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
8e-05 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0001 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |